Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

GZMB Antikörper (AA 21-247)

GZMB Reaktivität: Human BCA Wirt: Maus Monoclonal O94E6-GZMB unconjugated
Produktnummer ABIN2666250
  • Target Alle GZMB Antikörper anzeigen
    GZMB (Granzyme B (GZMB))
    Bindungsspezifität
    • 19
    • 16
    • 13
    • 9
    • 9
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 21-247
    Reaktivität
    • 123
    • 53
    • 25
    • 10
    • 4
    • 2
    • 1
    • 1
    Human
    Wirt
    • 78
    • 48
    • 2
    Maus
    Klonalität
    • 76
    • 52
    Monoklonal
    Konjugat
    • 79
    • 11
    • 8
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser GZMB Antikörper ist unkonjugiert
    Applikation
    • 72
    • 42
    • 40
    • 37
    • 17
    • 17
    • 17
    • 14
    • 13
    • 9
    • 9
    • 6
    • 6
    • 5
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Biochemical Assay (BCA)
    Aufreinigung
    The antibody was purified by affinity chromatography.
    Immunogen
    AA 21-247 of Human Granzyme B produced in E. coli.
    Klon
    O94E6-GZMB
    Isotyp
    IgG2a
    Top Product
    Discover our top product GZMB Primärantikörper
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    0.5 mg/mL
    Buffer
    Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C
    Informationen zur Lagerung
    Upon receipt, store undiluted at 4°C
  • Target
    GZMB (Granzyme B (GZMB))
    Andere Bezeichnung
    Granzyme B (GZMB Produkte)
    Synonyme
    CCPI antikoerper, CGL-1 antikoerper, CGL1 antikoerper, CSP-B antikoerper, CSPB antikoerper, CTLA1 antikoerper, CTSGL1 antikoerper, HLP antikoerper, SECT antikoerper, granzyme B antikoerper, GZMB antikoerper
    Hintergrund
    Granzyme B is a serine protease that is produced mainly by cytotoxic T cells (CTL) and natural killer (NK) cells. It plays an important role in cytotoxic lymphocyte-mediated apoptosis, chronic inflammation, and impaired wound healing. Granzyme B is packaged in cytoplasmic granules that are exocytosed towards a bound target cell, which subsequently activates multiple protein substrates that induce apoptosis. Perforin facilitates the transfer of Granzyme B into the target cell. Most circulating CD56+, CD8-, NK cells, and approximately half of circulating CD8+ T cells coexpress both Granzyme A and B. The activation of CD8+ and CD4+ T lymphocytes induce substantial expression of Granzyme B, but not Granzyme A. Recently, Granzyme B has been found to be produced by other cell types such as CD34+ hematopoietic progenitor cells, keratinocytes, basophils, mast cells, plasmacytoid dendritic cells, B cells, and smooth muscle cells. Elevated levels of Granzyme B are also found in some kinds of autoimmune diseases, type 1 diabetes, and cardiovascular diseases.
    Pathways
    Apoptose, Caspase Kaskade in der Apoptose
Sie sind hier:
Kundenservice